Systagenix Announces Milestone With 1,000 Clinicians Globally Trained in New Diagnostic Wound Test -- WOUNDCHEK™ Protease Status
GATWICK, England--(BUSINESS WIRE)--Systagenix announced today that more than 1,000 clinicians from over 400 sites across Europe, the Middle East and South Africa have now been trained in the four months since the launch of WOUNDCHEK™ Protease Status, the world’s first point of care test for Elevated Protease Activity (EPA) in chronic wounds.